| 產品編號 | bs-8275R-BF350 |
| 英文名稱 | Rabbit Anti-GPRIN1/BF350 Conjugated antibody |
| 中文名稱 | BF350標記的G蛋白調節(jié)誘導神經突增生蛋白1抗體 |
| 別 名 | G protein regulated inducer of neurite outgrowth 1; GRIN1; KIAA1893; Z16; GRIN1_HUMAN. |
| 規(guī)格價格 | 100ul/2980元 購買 大包裝/詢價 |
| 說 明 書 | 100ul |
| 研究領域 | 細胞生物 免疫學 神經生物學 G蛋白信號 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應 | (predicted: Human, ) |
| 產品應用 | IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 102kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human GPRIN1 (131-170aa) |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 產品介紹 |
background: GPRIN1 may be involved in neurite outgrowth. Function: May be involved in neurite outgrowth Subunit: Interacts with activated forms of GNAI1, GNAO1 and GNAZ Subcellular Location: Cell membrane; Lipid anchor. Cell projection growth cone. Note: Highly enriched in growth cone. Tissue Specificity: Widely expressed in the central nervous system, with highest levels in spinal cord. Post-translational modifications: Palmitoylation on Cys-999 and/or Cys-1000 is required for membrane targeting Database links: Entrez Gene: 114787 Human Omim: 611239 Human SwissProt: Q7Z2K8 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
